Ginkgo Bioworks
NYSE: DNABoston, US · Incorporated in Delaware · 3 known investors
Ginkgo Bioworks builds autonomous labs that accelerate bioengineering for applications in pharmaceutical, agricultural, and industrial biotechnology. The company serves biopharma, agritech, and industrial biotech companies seeking to engineer organisms at scale.
Founders & leadership
JK
Jason KellyCo-founder & CEO
RS
Reshma ShettyCo-founder, President & Chief Operations Officer
BC
Barry CantonFoundry Technology Strategy & Direction
AC
Austin CheStrategic Partnerships & Investments
TK
Tom KnightFounder, Ginkgo Fellow
Investors · 3
In the news
- Form 144 Ginkgo Bioworks Holdings For: 17 July By Investing.comca.investing.com · 2026
- What Does Ginkgo Bioworks' Strategic Pivot Mean for Investorskavout.com · 2026
- Ginkgo Bioworks raises $350 mln fund for biotech spinouts | Financial Postfinancialpost.com · 2019
- Ginkgo Bioworks Launches New Organism Foundry, Supported by $275 Million in Series D Fundingprnewswire.com · 2017
- Ginkgo Bioworks Raises $9 Million in Funding from Felicis Ventures, OS Fund and Data Collective | Fierce Biotechfiercebiotech.com · 2015